Oncolytics Biotech Inc (ONCY) Annual Balance Sheets

Annual · GAAP · USD millions
Access ONCY quarterly Balance Sheets →
Examining balance sheet movements between Oncolytics Biotech Inc and Dec 31 2021 reveals how Dec 31 2025 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent5.20
Cash And Cash Equivalents0.00
Cash & Short-term Investments5.00
Other Receivables, Net, Current0.57
Notes Receivable, Current0.53
Other Current Assets0.00
Prepaid Expense, Current AS0.15
Total Current Assets6.84
Equipment/Property/Plant Net0.23
Tax Assets, Noncurrent40.20
Other Assets, Noncurrent0.51
Other Current Receivables-
Current Prepaid Expenses-
Total Assets7.58
Liabilities
Accounts Payable, Current AC3.50
Accrued Liabilities, Current AC2.33
Derivative Liability, Current DE0.08
Other Liabilities, Current0.19
Total Current Liabilities6.10
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.15
Other liabilities, Noncurrent5.28
OperatingLeaseLiabilityNoncurrent0.37
Operating Lease Liability Current0.19
Noncurrent Contract Liabilities-
Total Liabilities11.38
Stockholders' Equity
Additional Paid In Capital Common Stock419.47
Retained Earnings / Accumulated Deficit-429.50
Accumulated Other Comprehensive Income6.23
Defined Benefit Plan and Other0.08
Other Equity6.23
Common Stockholder's Equity-3.80
Total Stockholder's Equity-3.80
Liabilities & Stockholder's Equity7.58
4 historic quarters locked

Sign in to unlock the full Oncolytics Biotech Inc balance sheet history.

About Oncolytics Biotech Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001129928-26-000020

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License